Literature DB >> 6657014

Causes of unfavorable outcome after early aneurysm operation.

B Ljunggren, H Säveland, L Brandt.   

Abstract

In a consecutive series of 160 patients in Hunt and Hess Neurological Grades I to III who were operated upon for a ruptured supratentorial aneurysm within 3 days after the hemorrhage, 42 patients (26%) had an unfavorable outcome. Delayed ischemic cerebral dysfunction with permanent deficit accounted for the unfavorable outcome in 18 patients (43% of all unfavorable results or 11% of the total series), whereas the unfavorable outcome was due to deficit ascribed to surgical trauma in 11 patients (26% of all unfavorable results or 7% of the total series) and to the initial hemorrhage in 7 patients (17% of all unfavorable results or 4% of the total series). Impaired outflow of cerebrospinal fluid with shunt dependency occurred in 3% of the total series. Of the patients with an unfavorable outcome, 17 (40%) had had arterial hypertension before the hemorrhage. The incidence of unfavorable outcome in good grade patients (Grades I and II) was not influenced by timing of operation (Day 1, 2, or 3 after hemorrhage). The results favor the opinion that it is principally the patient's condition during the acute stage that determines the outcome. (Neurosurgery 13:629-633, 1983).

Entities:  

Mesh:

Year:  1983        PMID: 6657014     DOI: 10.1227/00006123-198312000-00001

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  21 in total

1.  Intracerebral hematomas caused by aneurysm rupture. Experience with 67 cases.

Authors:  G Nowak; D Schwachenwald; R Schwachenwald; U Kehler; H Müller; H Arnold
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 2.  Aneurysmal subarachnoid hemorrhage: prevention of delayed ischemic dysfunction with intravenous nimodipine.

Authors:  B Ljunggren; L Brandt; H Säveland; B Romner; T Ryman; K E Andersson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

3.  Delayed cerebral ischaemia: the pathological substrate.

Authors:  G Neil-Dwyer; D A Lang; B Doshi; C J Gerber; P W Smith
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

4.  Contribution of non-neurologic disturbances in acute physiology to the prediction of intensive care outcome after head injury or non-traumatic intracranial haemorrhage.

Authors:  M M Niskanen; A Kari; J A Hernesniemi; M P Vapalahti; E Iisalo; L Kaukinen; V Rauhala; E Saarela; P Nikki
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

5.  Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage.

Authors:  E Vinge; K E Andersson; L Brandt; B Ljunggren; L G Nilsson; S Rosendal-Helgesen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  One-year outcome in early aneurysm surgery: prediction of outcome.

Authors:  M M Niskanen; J A Hernesniemi; M P Vapalahti; A Kari
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

7.  The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms.

Authors:  S Sakaki; S Ohta; H Kuwabara; M Shiraishi
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

8.  Shunt-dependent hydrocephalus after subarachnoid haemorrhage and aneurysm surgery: timing of surgery is not a risk factor.

Authors:  A Tapaninaho; J Hernesniemi; M Vapalahti; M Niskanen; A Kari; M Luukkonen; M Puranen
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  A simple scoring system for accurate prediction of outcome within four days of a subarachnoid haemorrhage.

Authors:  C J Gerber; D A Lang; G Neil-Dwyer; P W Smith
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

10.  CT-findings in haemorrhages from aneurysms of the anterior communicating artery: correlation with angiography and clinical course.

Authors:  P Stoeter; H J Reulen; U Groeger
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.